Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.

Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

September 03, 2019

News | Left Atrial Appendage (LAA) Occluders

AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices

August 28, 2019 — AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

August 28, 2019

An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire

Feature | Heart Valve Technology

BASILICA Procedure Prevents Coronary Obstruction From TAVR

A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve ...

August 27, 2019

Podcast | Structural Heart

PODCAST: Advice for Hospitals Starting A Structural Heart Program With John Carroll, M.D.

John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the ...

August 23, 2019

News | Stem Cell Therapies

Renovacor Closes $11 Million Series A Financing for New Cardiovascular Gene Therapy

August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...

August 22, 2019

News | Heart Valve Technology

Edwards Recalls Sapien 3 Ultra Delivery System Due to Burst Balloons During Surgery

August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst ...

August 22, 2019

News | Angiography

Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs

August 21, 2019 — Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac ...

August 21, 2019

News | Hypertension

Abnormal Blood Pressure in Middle And Late Life Influences Dementia Risk

August 20, 2019 — In a study that spanned two and a half decades and looked at data from more than 4,700 participants ...

August 20, 2019

News | Ventricular Assist Devices (VAD)

Experts Caution Against Catch-all Assumptions About LVADs and Mitral Regurgitation

August 20, 2019 — Left ventricular assist devices (LVADs) have been shown to help leaky mitral valves that create ...

August 20, 2019

News | Cardiac Diagnostics

Insomnia Tied to Higher Risk of Heart Disease and Stroke

August 19, 2019 — People suffering from insomnia may have an increased risk of coronary artery disease, heart failure an ...

August 19, 2019

FDA Approves Barostim Neo System for Advanced Heart Failure Patients. Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels.

Technology | Heart Failure

FDA Approves Pacemaker-like Device to Treat Heart Failure

August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...

August 19, 2019

FDA Approves Sapien 3, CoreValve Evolut TAVR Valves for Low-risk Patients

Feature | Heart Valve Technology | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor

FDA Approves TAVR for Low-risk Patients Creates A Paradigm Shift in Cardiology

August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of transcatheter ...

August 16, 2019

News | Hypertension

Blood Pressure Control Less Likely Among Those Treated in Low-income Areas

August 14, 2019 — People enrolled in a large clinical hypertension management trial were half as likely to control their ...

August 14, 2019

News | Heart Failure

Ancora Heart Enrolls First Patient in European Multi-center Study of AccuCinch Heart Failure Therapy

August 14, 2019 — Ancora Heart Inc. announced the first patient was enrolled in the CorCinch EU study, a European multi ...

August 14, 2019

Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurysm in the aortic arch. Image from GE Healthcare.

Feature | Structural Heart | Ashish Pershad, M.D., and Kenith Fang, M.D., FACS

National Coverage Determination Will Make TAVR Available to More Patients at More Centers

As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the ...

August 12, 2019